Log in
Registerscale average bioequivalence for parallel design [RSABE / ABEL]
Dear All
In the following paper
Statistical methodology for highly variable compounds: A novel design approach for the Ofatumumab Phase 2 bioequivalence study
Used scale average bioequivalence for parallel design
Is this method accepted by FDA and EMA
M.Youseef
Edit: Category changed; see also this post #1. [Helmut]
In the following paper
Statistical methodology for highly variable compounds: A novel design approach for the Ofatumumab Phase 2 bioequivalence study
Used scale average bioequivalence for parallel design
Is this method accepted by FDA and EMA
M.Youseef
Edit: Category changed; see also this post #1. [Helmut]
Complete thread:
- scale average bioequivalence for parallel designMahmoud 2022-06-15 12:33
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Parallel design: Maybe (‼) in exceptional cases Helmut 2022-06-15 14:08
- Parallel design: Maybe (‼) in exceptional cases Mahmoud 2022-06-15 23:26
- Parallel design: Maybe (‼) in exceptional cases Helmut 2022-06-15 14:08
Ing. Helmut Schütz